Mestinon

In some countries, this medicine may only be approved for veterinary use.

In the US, Mestinon (pyridostigmine systemic) is a member of the drug class cholinergic muscle stimulants and is used to treat Dysautonomia, Myasthenia Gravis, Nerve Agent Pretreatment and Reversal of Nondepolarizing Muscle Relaxants.

US matches:

• Mestinon


• Mestinon Controlled-Release Tablets


• Mestinon Syrup


• Mestinon Tablets


• Mestinon Timespan

UK matches:

• Mestinon 60 mg Tablets

Ingredient matches for Mestinon

Pyridostigmine

Pyridostigmine Bromide is reported as an ingredient of Mestinon in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Brazil


• Canada


• Chile


• Colombia


• Costa Rica


• Czech Republic


• Denmark


• Dominican Republic


• El Salvador


• Ethiopia


• Finland


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Malta


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Taiwan


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search